Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatin

Rationalization of the inhibition activity of structurally related organometallic compounds against the drug target cathepsin B by DFT

(2010) Angela Casini et al.   DALTON TRANSACTIONS

Reactivity of anticancer metallodrugs with serum proteins: new insights from size exclusion chromatography-ICP-MS and ESI-MS

(2010) Michael Groessl et al.   JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY

Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339

(2010) Petra Heffeter et al.   JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY

Ruthenium versus platinum: interactions of anticancer metallodrugs with duplex oligonucleotides characterised by electrospray ionisation mass spectrometry

(2010) Michael Groessl et al.   JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY

Stability, accumulation and cytotoxicity of an albumin-cisplatin adduct

(2010) Charlotte Møller et al.   Metallomics

Evaluation of cell lysis methods for platinum metallomic studies of human malignant cells

(2009) Mai Quynh Thanh Tran et al.   ANALYTICAL BIOCHEMISTRY

A Cytotoxic Ruthenium Tris(Bipyridyl) Complex that Accumulates at Plasma Membranes

(2009) Olivier Zava et al.   CHEMBIOCHEM

A categorization of metal anticancer compounds based on their mode of action

(2009) Teresa Gianferrara et al.   DALTON TRANSACTIONS

Platinum Anticancer Coordination Compounds: Study of DNA Binding Inspires New Drug Design

(2009) Jan Reedijk   EUROPEAN JOURNAL OF INORGANIC CHEMISTRY

Cytotoxicity, Hydrophobicity, Uptake, and Distribution of Osmium(II) Anticancer Complexes in Ovarian Cancer Cells

(2009) Sabine H. van Rijt et al.   JOURNAL OF MEDICINAL CHEMISTRY

The emerging role of ICP-MS in proteomic analysis

(2009) Jörg Bettmer et al.   Journal of Proteomics

Inhibition of transcription by platinum antitumor compounds

(2009) Ryan C. Todd et al.   Metallomics

Analytical methodologies for metallomics studies of antitumor Pt-containing drugs

(2009) Diego Esteban-Fernández et al.   Metallomics

The actin cytoskeleton in cancer cell motility

(2008) Michael F. Olson et al.   CLINICAL & EXPERIMENTAL METASTASIS

Capillary electrophoresis hyphenated to inductively coupled plasma-mass spectrometry: A novel approach for the analysis of anticancer metallodrugs in human serum and plasma

(2008) Michael Groessl et al.   ELECTROPHORESIS

Development of an experimental protocol for uptake studies of metal compounds in adherent tumor cells

(2008) Alexander E. Egger et al.   JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY

CZE–ICP-MS as a tool for studying the hydrolysis of ruthenium anticancer drug candidates and their reactivity towards the DNA model compound dGMP

(2008) Michael Groessl et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Analytical methodologies for the determination of cisplatin

(2008) M. Espinosa Bosch et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

The application of inductively coupled plasma mass spectrometry in clinical pharmacological oncology research

(2008) Elke E.M. Brouwers et al.   MASS SPECTROMETRY REVIEWS

Antitumour metal compounds: more than theme and variations

(2007) Michael A. Jakupec et al.   DALTON TRANSACTIONS